|
US20160000902A1
(en)
*
|
2003-07-11 |
2016-01-07 |
Novavax, Inc. |
Combination vaccine for respiratory syncytial virus and influenza
|
|
PT2347775T
(pt)
|
2005-12-13 |
2020-07-14 |
The President And Fellows Of Harvard College |
Estruturas em andaime para transplante celular
|
|
US9770535B2
(en)
|
2007-06-21 |
2017-09-26 |
President And Fellows Of Harvard College |
Scaffolds for cell collection or elimination
|
|
PL2222710T3
(pl)
*
|
2007-12-24 |
2017-01-31 |
Id Biomedical Corporation Of Quebec |
Rekombinowane antygeny rsv
|
|
US9370558B2
(en)
|
2008-02-13 |
2016-06-21 |
President And Fellows Of Harvard College |
Controlled delivery of TLR agonists in structural polymeric devices
|
|
US10328133B2
(en)
|
2008-02-13 |
2019-06-25 |
President And Fellows Of Harvard College |
Continuous cell programming devices
|
|
US11446374B2
(en)
|
2008-12-09 |
2022-09-20 |
Novavax, Inc. |
Modified RSV F proteins and methods of their use
|
|
JP5813513B2
(ja)
*
|
2008-12-09 |
2015-11-17 |
ノババックス，インコーポレイテッド |
修飾ｒｓｖｆタンパク質及びその使用方法
|
|
AU2010264686A1
(en)
*
|
2009-06-24 |
2012-01-19 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
MX2012000035A
(es)
*
|
2009-06-24 |
2012-02-28 |
Id Biomedical Corp Quebec |
Antigenos de virus de sincicio respiratorio recombinantes.
|
|
EP4218799A1
(en)
|
2009-07-15 |
2023-08-02 |
GlaxoSmithKline Biologicals S.A. |
Rsv f protein compositions and methods for making same
|
|
KR101346197B1
(ko)
*
|
2009-07-17 |
2014-02-06 |
한림대학교 산학협력단 |
리포좀에 포집된 올리고뉴클레오타이드 및 에피토프를 포함하는 면역증강용 조성물
|
|
EP2461828B1
(en)
*
|
2009-07-31 |
2017-06-21 |
President and Fellows of Harvard College |
Programming of cells for tolerogenic therapies
|
|
US8846056B2
(en)
*
|
2009-08-04 |
2014-09-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control |
Anti-RSV immunogens and methods of immunization
|
|
CN103037898B
(zh)
|
2010-07-07 |
2016-06-29 |
人工细胞科技公司 |
呼吸道合胞病毒抗原组合物和方法
|
|
JP6104806B2
(ja)
|
2010-10-06 |
2017-03-29 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
材料に基づく細胞治療のための注射可能孔形成性ハイドロゲル
|
|
AU2012211126A1
(en)
*
|
2011-01-28 |
2013-07-18 |
Medimmune, Llc |
Expression of soluble viral fusion glycoproteins in mammalian cells
|
|
CA2834349A1
(en)
*
|
2011-04-26 |
2012-11-01 |
Molecular Express, Inc. |
Liposomal formulations
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
EP2701745B1
(en)
|
2011-04-28 |
2018-07-11 |
President and Fellows of Harvard College |
Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
|
|
DK2707385T3
(da)
|
2011-05-13 |
2017-11-20 |
Glaxosmithkline Biologicals Sa |
RSV-F-præfusionsantigener
|
|
WO2012167230A1
(en)
|
2011-06-03 |
2012-12-06 |
President And Fellows Of Harvard College |
In situ antigen-generating cancer vaccine
|
|
ES2395677B1
(es)
*
|
2011-07-29 |
2013-12-26 |
Instituto De Salud Carlos Iii |
Proteína F del VRSH en conformación pre-fusión estabilizada y anticuerpos neutralizantes específicos frente a la misma.
|
|
WO2013031827A1
(ja)
|
2011-08-29 |
2013-03-07 |
国立大学法人徳島大学 |
Rsv粘膜ワクチン
|
|
US20130122032A1
(en)
*
|
2011-09-30 |
2013-05-16 |
Gale Smith |
Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus
|
|
CA2870182A1
(en)
*
|
2012-04-10 |
2013-10-17 |
The Trustees Of The University Of Pennsylvania |
Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
|
|
CN104244929B
(zh)
|
2012-04-16 |
2017-04-05 |
哈佛学院董事会 |
用于调节免疫反应的介孔二氧化硅组合物
|
|
MY171498A
(en)
*
|
2012-08-01 |
2019-10-15 |
Bavarian Nordic As |
Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
|
|
DK2879702T3
(da)
*
|
2012-08-01 |
2020-02-24 |
Bavarian Nordic As |
Rekombinant modificeret vacciniavirus ankara (mva)-vaccine mod respiratorisk syncytialvirus (rsv)
|
|
US20140037680A1
(en)
*
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
WO2014024026A1
(en)
|
2012-08-06 |
2014-02-13 |
Glaxosmithkline Biologicals S.A. |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
|
US20140227309A1
(en)
*
|
2013-02-11 |
2014-08-14 |
Novavax, Inc. |
Combination vaccine for respiratory syncytial virus and influenza
|
|
AU2014304545A1
(en)
|
2013-08-05 |
2016-02-25 |
Glaxosmithkline Biologicals S.A. |
Combination immunogenic compositions
|
|
JP7348708B2
(ja)
|
2014-04-30 |
2023-09-21 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
組み合わせワクチン装置および癌細胞を殺滅する方法
|
|
CN106659777A
(zh)
|
2014-06-13 |
2017-05-10 |
葛兰素史密丝克莱恩生物有限公司 |
免疫原性组合产品
|
|
HK1247861A1
(zh)
|
2015-01-30 |
2018-10-05 |
President And Fellows Of Harvard College |
用於癌症治疗的肿瘤周围和肿瘤内部材料
|
|
WO2016164705A1
(en)
|
2015-04-10 |
2016-10-13 |
Omar Abdel-Rahman Ali |
Immune cell trapping devices and methods for making and using the same
|
|
EP4494650A3
(en)
|
2015-09-03 |
2025-03-26 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
|
EP3393512B1
(en)
|
2015-12-23 |
2025-11-19 |
Pfizer Inc. |
Rsv f protein mutants
|
|
EP3411475B1
(en)
|
2016-02-06 |
2025-08-27 |
President and Fellows of Harvard College |
Recapitulating the hematopoietic niche to reconstitute immunity
|
|
CN115404196A
(zh)
|
2016-07-13 |
2022-11-29 |
哈佛学院院长等 |
抗原呈递细胞模拟支架及其制备和使用方法
|
|
CN110418651A
(zh)
|
2016-08-02 |
2019-11-05 |
哈佛学院院长等 |
用于调节免疫应答的生物材料
|
|
JP7044222B2
(ja)
|
2016-08-03 |
2022-03-30 |
ロンザ ウォーカーズヴィル，インコーポレーテッド |
実質的にコアギュローゲンを含まないリムルスアメボサイトライセートを使用してエンドトキシンを検出する方法
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
JP7507560B2
(ja)
|
2017-01-11 |
2024-06-28 |
ロンザ ウォーカーズヴィル，インコーポレーテッド |
コアギュローゲンを含まない、清澄化リムルスアメボサイトライセート
|
|
WO2019023196A1
(en)
|
2017-07-24 |
2019-01-31 |
Novavax, Inc. |
METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE
|
|
CN111527213A
(zh)
|
2017-10-16 |
2020-08-11 |
葛兰素史密丝克莱恩生物有限公司 |
具有两个编码rsv抗原蛋白或片段的表达盒的腺病毒载体
|
|
US20200299651A1
(en)
|
2017-10-16 |
2020-09-24 |
Glaxosmithkline Biologicals Sa |
Simian adenoviral vectors with two expression cassettes
|
|
CA3084358A1
(en)
|
2017-10-16 |
2019-04-25 |
Glaxosmithkline Biologicals Sa |
Enhanced promoter
|
|
US11905313B2
(en)
|
2017-11-28 |
2024-02-20 |
The United States of America, as represented by the Secretary, Department of Health and Human Services. |
Recombinant RSV G proteins and their use
|
|
EP3768308A4
(en)
|
2018-03-19 |
2022-01-26 |
Novavax, Inc. |
MULTIVALENT INFLUENZA NANOPARTICLE VACCINES
|
|
JP2021526831A
(ja)
|
2018-06-12 |
2021-10-11 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
アデノウイルスポリヌクレオチド及びポリペプチド
|
|
WO2020061129A1
(en)
|
2018-09-19 |
2020-03-26 |
President And Fellows Of Harvard College |
Compositions and methods for labeling and modulation of cells in vitro and in vivo
|
|
KR102725189B1
(ko)
|
2018-11-01 |
2024-10-31 |
에스케이바이오사이언스(주) |
재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물
|
|
AU2020227545B2
(en)
|
2019-02-28 |
2023-10-19 |
Km Biologics Co., Ltd. |
RSV F/G chimeric vaccine
|
|
WO2021061837A1
(en)
|
2019-09-23 |
2021-04-01 |
President And Fellows Of Harvard College |
Biomaterial-based antigen free vaccine and the use thereof
|
|
CN114993784B
(zh)
*
|
2022-05-27 |
2025-07-29 |
重庆医科大学 |
一种乙肝病毒颗粒裂解液及其制备与应用
|
|
WO2025263563A1
(ja)
*
|
2024-06-20 |
2025-12-26 |
Ｋｍバイオロジクス株式会社 |
ＲＳＶ ＦＧキメラｍＲＮＡワクチン
|